ISN Series on Transplantation: Personalized Care & Therapies: Individualized Risk and Treatment after Transplantation

REGISTRATION

ISN Series on Transplantation: Personalized Care & Therapies: Individualized Risk and Treatment after Transplantation

Personalized care after kidney transplantation mainly includes the following strategies:

  • the personalized choice of the immunosuppressive regimen (induction and maintenance) to prevent acute rejection while reducing of long-term consequences of over-immunosuppression;
  • the personalized targeted prophylaxis against opportunistic infection; and,
  • pharmacogenomic approaches to personalized post-transplant care. This webinar will offer an overview of the above three strategies, before focusing in on the choice of the immunosuppressive regimen.

Learning Objectives

  • Provide an overview of the following strategies for personalized care:
    • the personalized choice of the immunosuppressive regimen
    • the personalized targeted prophylaxis against opportunistic infection
    • pharmacogenomic approaches to personalized post-transplant care
  • Discuss in detail the personalized choice of the immunosuppressive regimen (induction and maintenance) to prevent acute rejection while reducing long-term consequences of over-immunosuppression.
  • Discuss possible individualized therapies for the prevention and treatment of opportunistic infections

CME Credits

“The ISN Series on Transplantation: Personalized Care & Therapies: Individualized Risk and Treatment after Transplantation, Brussels, Belgium, 14/11/2022-14/11/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”

“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.”

“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

You may only claim CME credits if you attend the live webinar.

Further Reading

  • Novel Biomarkers in Kidney Transplantation; Yatim, Karim M. et al.Seminars in Nephrology, Volume 42, Issue 1, 2 – 13
  • The Complement System in the Modern Era of Kidney Transplantation: Mechanisms of Injury and Targeted Therapies; Kamel, Mohamed Hassan et al.; Seminars in Nephrology, Volume 42, Issue 1, 14 – 28
  • Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach;Zanoni, Francesca et al.;Seminars in Nephrology, Volume 42, Issue 1, 29 – 43
  • Histocompatibility Assessment in Precision Medicine for Transplantation: Towards a Better Match; Yeung, Melissa Y.;Seminars in Nephrology, Volume 42, Issue 1, 44 – 62
  • Emerging Concepts in Managing Malignancy in Kidney Transplant Patients; Schreiber, Brittany et al.; Seminars in Nephrology, Volume 42, Issue 1, 63 – 75
  • Transplantation in the Age of Precision Medicine: The Emerging Field of Treg Therapy; Rickert, Charles G. et al.;Seminars in Nephrology, Volume 42, Issue 1, 76 – 85
  • Immunosuppression in the Age of Precision Medicine; Gabardi, Steven; Seminars in Nephrology, Volume 42, Issue 1, 86 – 98
  • Precision Medicine and Personalized Approach to Renal Transplantation; Dafoe, Donald C. et al.; Seminars in Nephrology, Volume 38, Issue 4, 346 – 354

This webinar is supported by industry.

14 November, 10 am CEST